Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection

Area of Science:

• Immunology
• Infectious Diseases
• Parasitology

Background:

• Leishmaniasis is a significant parasitic disease with diverse clinical presentations.
• Accurate diagnostic tools are crucial for disease management and control.
• Current diagnostic methods may have limitations in certain settings.

Purpose of the Study:

• To evaluate the QuantiFERON assay's ability to detect Leishmania infection.
• To assess interferon-gamma (IFN-γ) secretion in response to leishmanial antigens.
• To explore the assay's potential for epidemiological screening of leishmaniasis.

Main Methods:

• Blood samples were collected from patients with cured visceral leishmaniasis (N=18), cutaneous leishmaniasis (N=20), and healthy controls (N=20).
• The QuantiFERON assay was employed to measure IFN-γ secretion by T cells.
• Leishmania major H2B and Leishmania infantum H2B antigens were used for stimulation.

Main Results:

• IFN-γ responses were detected in the majority of treated visceral leishmaniasis cases.
• No significant IFN-γ responses were observed in healthy controls.
• Responses in cutaneous leishmaniasis cases were not explicitly detailed but implied to be less prominent than in visceral cases.

Conclusions:

• The QuantiFERON assay shows promise as a tool for detecting past Leishmania infections, particularly visceral leishmaniasis.
• Further research with larger cohorts is necessary to validate its efficacy for epidemiological screening.
• This assay could potentially aid in understanding leishmaniasis transmission dynamics.